一种新合成的环己烷-羟基酪醇衍生物通过诱导 ROS 和阻断自噬通量抑制卵巢癌细胞的生长。

IF 5.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Antioxidants & redox signaling Pub Date : 2024-09-01 Epub Date: 2024-03-27 DOI:10.1089/ars.2023.0400
Guanfei Zhang, Min Wang, Yilin Gao, Aikaterini Christina Komianou, Eleftheria A Georgiou, Yan Wang, Yezi Zheng, Jiankang Liu, Ioannis K Kostakis, Lin Zhao
{"title":"一种新合成的环己烷-羟基酪醇衍生物通过诱导 ROS 和阻断自噬通量抑制卵巢癌细胞的生长。","authors":"Guanfei Zhang, Min Wang, Yilin Gao, Aikaterini Christina Komianou, Eleftheria A Georgiou, Yan Wang, Yezi Zheng, Jiankang Liu, Ioannis K Kostakis, Lin Zhao","doi":"10.1089/ars.2023.0400","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8011,"journal":{"name":"Antioxidants & redox signaling","volume":" ","pages":"430-461"},"PeriodicalIF":5.9000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Novel Synthesized Cyclohexane-Hydroxytyrosol Derivative Suppresses Ovarian Cancer Cell Growth Through Inducing Reactive Oxidative Species and Blocking Autophagic Flux.\",\"authors\":\"Guanfei Zhang, Min Wang, Yilin Gao, Aikaterini Christina Komianou, Eleftheria A Georgiou, Yan Wang, Yezi Zheng, Jiankang Liu, Ioannis K Kostakis, Lin Zhao\",\"doi\":\"10.1089/ars.2023.0400\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":8011,\"journal\":{\"name\":\"Antioxidants & redox signaling\",\"volume\":\" \",\"pages\":\"430-461\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antioxidants & redox signaling\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1089/ars.2023.0400\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antioxidants & redox signaling","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/ars.2023.0400","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:卵巢癌(OC)细胞的耐药性往往导致卵巢癌患者复发、转移和高死亡率。据报道,羟基酪醇(HT)可抑制卵巢癌和其他类型癌细胞的增殖。在此,我们合成了一种新型环己烷-羟基酪醇衍生物(Chx-HT),以增强抗癌药物的疗效。我们考察了 Chx-HT 在体外和异种移植小鼠模型中对 OC 细胞的生长抑制作用,并研究了其潜在机制:结果:我们发现 Chx-HT 在体外和体内都能抑制细胞增殖、促进细胞凋亡、通过减少脂肪酸β-氧化重塑葡萄糖和脂质代谢,同时增加糖酵解、新脂肪酸合成和脂滴积累、损害线粒体呼吸并诱导氧化应激。此外,Chx-HT 在晚期通过阻碍溶酶体酪蛋白的成熟来阻断自噬通量,但也会在能量不足时通过 p-AMPK/p-mTOR/p-ULK1 途径激活自噬:ROS在介导Chx-HT对卵巢癌细胞增殖、凋亡、自噬、TCA循环、FAO和线粒体呼吸的影响中起着关键作用,而自噬激活是Chx-HT对卵巢癌细胞糖酵解、新脂肪酸合成和脂滴积累的影响的基础。用Chx-HT和自噬抑制剂或糖酵解抑制剂共处理卵巢癌细胞会产生相加的增殖抑制作用。我们的研究表明,Chx-HT 通过抑制 ROS 和自噬介导的代谢重塑,是一种很有前景的卵巢癌治疗药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Novel Synthesized Cyclohexane-Hydroxytyrosol Derivative Suppresses Ovarian Cancer Cell Growth Through Inducing Reactive Oxidative Species and Blocking Autophagic Flux.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Antioxidants & redox signaling
Antioxidants & redox signaling 生物-内分泌学与代谢
CiteScore
14.10
自引率
1.50%
发文量
170
审稿时长
3-6 weeks
期刊介绍: Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas. ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes. ARS coverage includes: -ROS/RNS as messengers -Gaseous signal transducers -Hypoxia and tissue oxygenation -microRNA -Prokaryotic systems -Lessons from plant biology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信